noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

CytomX Therapeutics Inc.

Statement of Changes in Beneficial Ownership (Form 4)
OXY - Occidental College

Occidental Accepts 2026 NCAA/MOAA Award for Opportunities and Impact
Alex Padilla

Padilla, Schumer Slam Trump Administration’s Efforts to Undo Offshore[...]

Healthcare

VistaGen Therapeutics Inc.

06/17/2026 | Press release | Distributed by Public on 06/17/2026 15:14

Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers.

On June 16, 2026, Ms. Margaret FitzPatrick, and on June 17, 2026, Dr. Joanne Curley, each a member of the Board of Directors of Vistagen Therapeutics, Inc. (the "Company"), notified the Company of her decision not to stand for re-election at the Company's 2026 Annual Meeting of Stockholders (the "2026 Annual Meeting"). Each will continue to serve as a director until the end of her term at the 2026 Annual Meeting.

VistaGen Therapeutics Inc. published this content on June 17, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 17, 2026 at 21:14 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]